Patent · US Active

Formulations of pegylated arginine deiminase

US12370242B2 · kind B2 · utility

0Cited by

14References

20Claims

0Family size

Assignee

POLARIS GROUP · KY

Inventors

Bor-Wen Wu · San Diego, US
James W. Thomson · Albany, US
Wen-Chin Tsai · Taipei, TW

Key dates

Filing date	Nov 2, 2017
Grant date	Jul 29, 2025
Priority date	—
Expiry date	Nov 2, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y305/03006
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are lyophilized formulations comprising pegylated arginine deiminase (ADI-PEG) and related reconstituted liquid compositions and methods of using the compositions for arginine depletion therapies, including for the treatment of various cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.